How has been the historical performance of Amrutanjan Healt?

Answer:The historical performance of Amrutanjan Healt shows a consistent growth in net sales and profit over the years, with significant increases noted from 2011 to 2017.

Breakdown:
Amrutanjan Healt's net sales have risen from 105.41 Cr in March 2011 to 231.70 Cr in March 2017, reflecting a strong upward trend. Other operating income also increased, contributing to a total operating income of 234.59 Cr in March 2017, up from 105.41 Cr in March 2011. The total expenditure, excluding depreciation, rose from 92.46 Cr in March 2011 to 205.57 Cr in March 2017, indicating higher operational costs alongside revenue growth. Operating profit (PBDIT) reached 33.85 Cr in March 2017, although it showed a slight decline from 36.34 Cr in March 2016. Profit before tax increased to 33.24 Cr in March 2017, while profit after tax also grew to 21.14 Cr from 10.43 Cr in March 2011. The earnings per share (EPS) improved from 3.44 in March 2011 to 7.23 in March 2017, showcasing enhanced profitability per share. The company's total assets increased from 156.69 Cr in March 2011 to 140.44 Cr in March 2016, while total liabilities were 140.44 Cr in March 2016, reflecting a stable financial position. Cash flow from operating activities improved significantly, reaching 20.70 Cr in March 2016, up from 5.70 Cr in March 2011, indicating better cash generation capabilities. Overall, Amrutanjan Healt has demonstrated robust growth in sales and profitability over the years, despite fluctuations in operating margins and costs.